Pharmaceuticals & Biotech
Pharmaceuticals & Biotech
Changes in the pharmaceuticals and biotech industries demand new thinking by those looking to rationalize costs, enhance operational efficiency and improve business agility.
We work with industry leaders to improve product development and manufacturing processes across key operational functions.
Cognizant offers a broad array of consulting and solutions for Life Sciences, Global Pharmaceutical and Biotech companies.
The SmartTrials platform provides real-time risk assessment and global clinical trial oversight to help companies reduce risk and improve collaboration, quality and compliance.
Cognizant offers solutions specific to the challenges of Life Sciences companies. Browse the pages below to learn more.
IDC has positioned Cognizant’s offerings and capabilities in the Leaders category in WorldWide Life Science Manufacturing and Supply Chain and Sales and Marketing Digital Transformation. Read the reports to learn more.
Cognitive Computing: The Next Stage in Human/Machine Coevolution
Cognitive computing is extending our capacities in realms such as sensory perception, decision-making, and knowledge representation and processing. This next step in human/technology interactivity powerfully enhances our personal and professional lives.
Recoding the Customer Experience
Artificial intelligence (AI), machine learning (ML), and the Internet of Things are gaining momentum across enterprise environments. By incorporating these technologies into their strategic agendas, organizations industry-wide can streamline processes, anticipate customers’ needs and behaviors in real time, stimulate profitable growth, and deliver experiences that live up to the promise of digital.
Taking Control of the MLR Review Process
For pharmaceuticals and biotech companies, medical, legal, and regulatory reviews (MLRs) are commonplace, and help ensure that product claims, promotions, and training are medically correct, and in compliance with FDA and other industry standards. This requires companies to develop an MLR process that helps assure the accuracy, relevancy, and value of the promotional material they produce and market.
The Work Ahead: How Data and Digital Mastery Will Usher In an Era of Innovation and Collaboration
In this installment of our Work Ahead series, we focus on the impact of digital transformation on the life sciences industry and what it will take to transform an industry value chain in need of drastic modernization.
Preparing for the Regulatory Challenges Wrought by Software as a Medical Device
In the rapidly evolving digital health ecosystem, software as a medical device (SaMD) plays an increasingly critical role for medical device manufacturers and other stakeholders, and understanding regulatory policies covering such software is key for determining QMS requirements.
An Analytical Approach to Provider and Intermediary Segmentation in the Pharmaceuticals Industry
In today's managed markets, pharmaceuticals companies that apply analytical approaches to market segmentation to providers and intermediaries such as health plans and pharmacy benefit managers gain competitive advantage through market-driven strategies, effective therapy launches and maximizing the value of in-line brands. We explore a number of clustering techniques to enable such analyses.
Helping Pharmas Manage Compliance Risks for Speaker Programs
To avoid stiff fees, reputation damage and the imposition of corporate integrity agreements (CIAs), pharmaceuticals companies need to monitor their speaker programs carefully for compliance to a suite of regulations. We identify those rules and outline a rigorous process based on relevant key performance indicators (KPIs) that will enable pharmas to head off these potential major hits to their bottom line.
The Internet of Things: The New Rx for Pharmaceuticals Manufacturing & Supply Chains
Product quality, regulatory compliance, and operational efficiency are chief concerns for pharmaceuticals executives, particularly in the areas of manufacturing and supply chain management. Yet the challenges of batch manufacturing have made it difficult to monitor the logistical journey of pharmaceutical products, which are subject to degradation, recalls, and strict regulatory standards. Using IoT platforms and solutions, pharmaceuticals companies can digitize and connect vital functions, achieve higher levels of quality and productivity, keep up with regulatory demands, and afford real-time visibility into virtually every area of the business.
How Decision-Support Tools Cure the Prior Authorization Time Drain
A collaboration between Cognizant, the New England Healthcare Exchange Network and Informatics In Context is demonstrating how a real-time prior authorization (PA) system for medical and administrative processes saves time and money.
The Internet of Things: An Excellent Prognosis for Medical Device Makers
By taking advantage of the Internet of Things (IoT), medical device manufacturers can focus squarely and consistently on the customer, rather than the device itself; monitor the performance and track the use of their products in real time; and operate within an automated, integrated environment that closes the gap between users, device makers, and technology providers.
A large pharmaceutical company with over 6,000 employees wanted to simplify the customer management information that was distributed in multiple systems across its sales and marketing organization. Cognizant designed, developed and implemented a system that consolidated all the information to a single point data source for other sales and marketing systems, including the CRM system.
The new system was developed using Web-based technology utilizing a combination of J2EE and EAI technology (TIBCO).
With major R&D sites in Sweden, the U.K. and the U.S., a global pharmaceutical client turned to Cognizant to provide IT delivery support for its research scientist community. Cognizant delivered a combination of onsite and remote infrastructure management (RIM) support, increasing coverage and driving higher levels of user satisfaction.
Our team also employed Lean and Six Sigma methodologies to drive continuous improvement in process areas throughout the research labs.DOWNLOAD PDF
To comply with The Physician Payment Sunshine Act, a large pharmaceutical client faced the difficult task of integrating disparate data tracking methods used to capture physician payments. The client needed Cognizant’s support to re-engineer the client’s processes, as payment information was not being captured to the level of detail required for reporting purposes.
Cognizant leveraged the Pega BPM suite to implement core compliance capabilities. The new system standardized business processes, integrated disparate systems and captured details needed for transparency of reporting.DOWNLOAD PDF
A major biopharmaceutical company’s global safety organization wanted to close its cases within one business day, regardless of the time or locale of origination. This would have required expensive new call centers, case processors and medical reviewers around the globe.
Rather than setting up new facilities and hiring people, the firm turned to Cognizant for an outcome-based service delivery model. Today cases are processed around the clock, around the world, with virtual teams of globally based experts and operational teams sharing data.DOWNLOAD PDF
This Cognizant webinar provides an orientation to the five stages required to implement a sound cloud application validation strategy.